# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Goldman Sachs Conference
- Reuters Citing Goldman Sachs Conference
- The Information
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.